Background-Bicuspid aortic valve is frequent and is reported to cause numerous complications, but the clinical outcome of patients diagnosed with normal or mildly dysfunctional valve is undefined. Methods and Results-In 212 asymptomatic community residents from Olmsted County, Minn (age, 32Ϯ20 years; 65% male), bicuspid aortic valve was diagnosed between 1980 and 1999 with ejection fraction Ն50% and aortic regurgitation or stenosis, absent or mild. Aortic valve degeneration at diagnosis was scored echocardiographically for calcification, thickening, and mobility reduction (0 to 3 each), with scores ranging from 0 to 9. At diagnosis, ejection fraction was 63Ϯ5% and left ventricular diameter was 48Ϯ9 mm. Survival 20 years after diagnosis was 90Ϯ3%, identical to the general population (Pϭ0.72). Twenty years after diagnosis, heart failure, new cardiac symptoms, and cardiovascular medical events occurred in 7Ϯ2%, 26Ϯ4%, and 33Ϯ5%, respectively. Twenty years after diagnosis, aortic valve surgery, ascending aortic surgery, or any cardiovascular surgery was required in 24Ϯ4%, 5Ϯ2%, and 27Ϯ4% at a younger age than the general population (PϽ0.0001). No aortic dissection occurred. Thus, cardiovascular medical or surgical events occurred in 42Ϯ5% 20 years after diagnosis. Independent predictors of cardiovascular events were age Ն50 years (risk ratio, 3.0; 95% confidence interval, 1.5 to 5.7; PϽ0.01) and valve degeneration at diagnosis (risk ratio, 2.4; 95% confidence interval, 1.2 to 4.5; Pϭ0.016; Ͼ70% events at 20 years). Baseline ascending aorta Ն40 mm independently predicted surgery for aorta dilatation (risk ratio, 10.8; 95% confidence interval, 1.8 to 77.3; PϽ0.01). Conclusions-In the community, asymptomatic patients with bicuspid aortic valve and no or minimal hemodynamic abnormality enjoy excellent long-term survival but incur frequent cardiovascular events, particularly with progressive valve dysfunction. Echocardiographic valve degeneration at diagnosis separates higher-risk patients who require regular assessment from lower-risk patients who require only episodic follow-up. (Circulation. 2008;117:2776-2784.)